Ulrik Pedersen-Bjergaard Selected Research

Ulrik Pedersen-Bjergaard Research Topics

Disease

72	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 03/2008
41	Hypoglycemia (Reactive Hypoglycemia) 04/2024 - 04/2003
26	Type 2 Diabetes Mellitus (MODY) 06/2024 - 11/2006
5	Cognitive Dysfunction 01/2023 - 03/2008
4	Diabetes Mellitus 01/2022 - 05/2018
4	Hyperglycemia 07/2021 - 06/2018
3	Neoplasms (Cancer) 01/2023 - 10/2014
3	COVID-19 01/2022 - 11/2020
3	Nausea 01/2020 - 01/2008
2	Critical Illness (Critically Ill) 05/2024 - 12/2022
2	Infections 01/2022 - 11/2020
2	Cardiac Arrhythmias (Arrythmia) 12/2021 - 07/2021
2	Ischemia 01/2020 - 02/2017
2	Spinal Cord Compression 06/2018 - 05/2018
2	Vomiting 03/2016 - 01/2008
2	Inappropriate ADH Syndrome (SIADH) 10/2014 - 12/2012
1	Thrombosis (Thrombus) 04/2024
1	Necrosis 11/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 02/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2021
1	Hypersensitivity (Allergy) 11/2020
1	Glucose Intolerance 11/2020
1	Fever (Fevers) 08/2020
1	Edema (Dropsy) 08/2018
1	Brain Neoplasms (Brain Tumor) 08/2018
1	ST Elevation Myocardial Infarction 02/2017
1	Reperfusion Injury 02/2017
1	Coronary Occlusion 02/2017
1	Weight Loss (Weight Reduction) 03/2016
1	Dyspepsia (Indigestion) 03/2016
1	Overweight 03/2016

Drug/Important Bio-Agent (IBA)

52	Insulin (Novolin)FDA Link 05/2024 - 03/2005
42	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2008
14	Hypoglycemic Agents (Hypoglycemics)IBA 01/2024 - 04/2003
9	Blood Glucose (Blood Sugar)IBA 03/2024 - 12/2013
7	Insulin Glargine (Lantus)FDA Link 09/2023 - 07/2019
7	insulin degludecIBA 09/2023 - 07/2019
5	Epinephrine (Adrenaline)FDA LinkGeneric 03/2024 - 05/2015
5	Long-Acting Insulin (Insulin, Long Acting)FDA Link 12/2022 - 06/2012
5	GlucocorticoidsIBA 06/2020 - 05/2018
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2015 - 03/2008
4	Hormones (Hormone)IBA 03/2024 - 01/2013
4	Glucagon (Glukagon)FDA Link 03/2024 - 11/2016
3	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2024 - 03/2016
3	Growth Hormone (Somatotropin)IBA 02/2024 - 12/2015
3	Insulin Detemir (Levemir)FDA Link 11/2021 - 07/2014
3	C-PeptideIBA 01/2018 - 06/2009
2	Interleukin-10 (Interleukin 10)IBA 11/2023 - 12/2022
2	Short-Acting InsulinIBA 08/2023 - 12/2022
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 05/2015
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 12/2021
2	Isophane Insulin (NPH Insulin)FDA Link 11/2021 - 06/2020
2	CarbohydratesIBA 01/2020 - 06/2018
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 02/2017
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 03/2016
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 11/2010
2	Liraglutide FDA Link 02/2017 - 03/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2015 - 11/2009
2	Vasopressins (Vasopressin)IBA 10/2014 - 12/2012
2	Erythropoietin FDA Link 01/2013 - 07/2009
1	Metformin (Glucophage)FDA LinkGeneric 06/2024
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 04/2024
1	Hemostatics (Antihemorrhagics)IBA 04/2024
1	GoldIBA 03/2024
1	Glycerol (Glycerine)FDA LinkGeneric 03/2024
1	InsulinsIBA 01/2023
1	Oleic AcidsIBA 01/2023
1	P-2 (P 2)IBA 01/2023
1	Isoleucine (L-Isoleucine)FDA Link 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Amino Acids FDA Link 01/2023
1	Branched-Chain Amino AcidsIBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	(L)-Isomer Glucose (L-Glucose)IBA 12/2022
1	C-Reactive ProteinIBA 12/2022
1	InterleukinsIBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2022
1	Hand SanitizersIBA 01/2022
1	Pioglitazone (Actos)FDA Link 11/2020
1	Oxygen (Dioxygen)IBA 08/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Insulin Aspart (NovoLog)FDA Link 10/2016
1	Saline SolutionIBA 03/2016
1	Angiotensin Receptor AntagonistsIBA 12/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2015
1	candesartanIBA 12/2015

Therapy/Procedure

19	Therapeutics 04/2024 - 11/2006
6	Injections 03/2024 - 01/2020
2	Glycemic Control 01/2022 - 07/2012
2	Subcutaneous Injections 01/2020 - 03/2016
1	Polypharmacy 01/2020
1	Transjugular Intrahepatic Portasystemic Shunt 06/2018
1	Radiotherapy 05/2018
1	Ischemic Postconditioning 02/2017